105 related articles for article (PubMed ID: 7494857)
21. Differential Biological Activities of Swine Interferon-α Subtypes.
Zanotti C; Razzuoli E; Crooke H; Soule O; Pezzoni G; Ferraris M; Ferrari A; Amadori M
J Interferon Cytokine Res; 2015 Dec; 35(12):990-1002. PubMed ID: 26447602
[TBL] [Abstract][Full Text] [Related]
22. A structural basis for interferon-alpha-receptor interactions.
Kumaran J; Wei L; Kotra LP; Fish EN
FASEB J; 2007 Oct; 21(12):3288-96. PubMed ID: 17517919
[TBL] [Abstract][Full Text] [Related]
23. Transcription factors in interferon signaling.
David M
Pharmacol Ther; 1995 Feb; 65(2):149-61. PubMed ID: 7540766
[TBL] [Abstract][Full Text] [Related]
24. The Role of Type I Interferon Subtypes and Interferon-Gamma in Type I Interferon Diabetes Inhibitory Activity in the NOD Mouse.
Sobel D; Ahvazi B; Pontzer C
J Interferon Cytokine Res; 2016 Apr; 36(4):238-46. PubMed ID: 26716812
[TBL] [Abstract][Full Text] [Related]
25. Definition of receptor binding domains in interferon-alpha.
Fish EN
J Interferon Res; 1992 Aug; 12(4):257-66. PubMed ID: 1431305
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site.
Roisman LC; Jaitin DA; Baker DP; Schreiber G
J Mol Biol; 2005 Oct; 353(2):271-81. PubMed ID: 16171819
[TBL] [Abstract][Full Text] [Related]
27. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains.
Takaoka A; Mitani Y; Suemori H; Sato M; Yokochi T; Noguchi S; Tanaka N; Taniguchi T
Science; 2000 Jun; 288(5475):2357-60. PubMed ID: 10875919
[TBL] [Abstract][Full Text] [Related]
28. Biological basis for a proper clinical application of alpha interferons.
Antonelli G
New Microbiol; 2008 Jul; 31(3):305-18. PubMed ID: 18843884
[TBL] [Abstract][Full Text] [Related]
29. Alpha-interferon structure and natural killer cell stimulatory activity.
Li BL; Zhao XX; Liu XY; Kim HS; Raska K; Ortaldo JR; Schwartz B; Pestka S
Cancer Res; 1990 Sep; 50(17):5328-32. PubMed ID: 2201435
[TBL] [Abstract][Full Text] [Related]
30. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver.
Salazar-Mather TP; Lewis CA; Biron CA
J Clin Invest; 2002 Aug; 110(3):321-30. PubMed ID: 12163451
[TBL] [Abstract][Full Text] [Related]
31. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
Walter MR; Bordens R; Nagabhushan TL; Williams BR; Herberman RB; Dinarello CA; Borden EC; Trotta PP; Pestka S; Pfeffer LM
Cancer Biother Radiopharm; 1998 Jun; 13(3):143-54. PubMed ID: 10850350
[TBL] [Abstract][Full Text] [Related]
32. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
33. Effects of interferons α/β on the proliferation of human micro- and macrovascular endothelial cells.
Erdmann J; Vitale G; van Koetsveld PM; Croze E; Sprij-Mooij DM; Hofland LJ; van Eijck CH
J Interferon Cytokine Res; 2011 May; 31(5):451-8. PubMed ID: 21361792
[TBL] [Abstract][Full Text] [Related]
34. Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists.
Pan M; Kalie E; Scaglione BJ; Raveche ES; Schreiber G; Langer JA
Biochemistry; 2008 Nov; 47(46):12018-27. PubMed ID: 18937499
[TBL] [Abstract][Full Text] [Related]
35. The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening.
Chill JH; Nivasch R; Levy R; Albeck S; Schreiber G; Anglister J
Biochemistry; 2002 Mar; 41(11):3575-85. PubMed ID: 11888273
[TBL] [Abstract][Full Text] [Related]
36. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
37. Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit.
Kumaran J; Colamonici OR; Fish EN
J Interferon Cytokine Res; 2000 May; 20(5):479-85. PubMed ID: 10841076
[TBL] [Abstract][Full Text] [Related]
38. Expression and biological activity of two recombinant polypeptides related to subunit 1 of the interferon-alpha receptor.
Yoon S; Hirata RD; Nguyen NY; Curi R; Russo M; Hirata MH
Braz J Med Biol Res; 2000 Jul; 33(7):771-8. PubMed ID: 10881052
[TBL] [Abstract][Full Text] [Related]
39. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways.
Malmgaard L; Salazar-Mather TP; Lewis CA; Biron CA
J Virol; 2002 May; 76(9):4520-5. PubMed ID: 11932417
[TBL] [Abstract][Full Text] [Related]
40. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.
White LJ; Wang JG; Davis NL; Johnston RE
J Virol; 2001 Apr; 75(8):3706-18. PubMed ID: 11264360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
